Abstract
The balance between interleukin-1 (IL-1) and its competitive antagonist IL-1 receptor antagonist (IL-1Ra) may contribute to the pathogenesis of rheumatoid arthritis (RA). We analysed the frequency of different alleles in the IL-1B gene (at −511 and at +3954) as well as in the IL-1Ra gene (at +2018) in an association study involving 297 RA patients and 112 healthy controls from the same geographic area. We tested associations with RA susceptibility or severity, and with circulating levels of IL-1Ra and IL-1β. Carriage of the rare IL-1B (+3954) allele 2 was increased in destructive arthritis (DRA) as compared to non-destructive arthritis (NDRA) (OR 1.7, 95% CI 1.1–2.8, 49.0% vs 35.9%) and controls (OR 1.7, 95% CI 1.1–2.8, 35.8%). Patients carrying this allele had a more destructive (Larsen wrist radiological index: mean ± s.e.m., 2.1 ± 0.2 vs 1.6 ± 0.1, P = 0.005; Steinbrocker functional index: 2.4 ± 0.1 vs 1.9 ± 0.1, P = 0.002) and active disease (Ritchie articular index: 8.1 ± 0.8 vs 5.3 ± 0.6, P = 0.002; erythrocyte sedimentation rate (ESR): 36.6 ± 2.9 mm/h vs 25.3 ± 1.8 mm/h, P = 0.002). This contribution was independent from that of HLA DR4/DR1 to severity. IL-1Ra plasma levels adjusted to ESR values were significantly lower in IL-1B2 (+3954) positive than negative RA patients (1.0 ± 0.1 vs 1.2 ± 0.1 ng/ml, P = 0.01). This IL-1B (+3954) gene polymorphism may be an important marker for the severity of joint destruction in RA and is associated with an imbalance in IL-1Ra production. As this genetic association was independent and additive to the risk of HLA DR4/DR1 status, it could be a useful addition to HLA-DR4/1 as a genetic prognostic marker early in the course of the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deighton CM, Walker DJ, Griffiths ID, Roberts DF The contribution of HLA to rheumatoid arthritis Clin Genet 1989 36 178–182
Cornelis F, Faure S, Martinez M et al New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study Proc Natl Acad Sci USA 1998 95 10746–10750
Nicklin MJ, Weith A, Duff GW A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes Genomics 1994 19 382–384
Arend WP, Dayer JM Inhibition of the production and effects of Interleukin-1 and Tumor Necrosis Factor α in rheumatoid arthritis Arthritis Rheum 1995 38 151–160
Hopkins SJ, Humphreys M, Jayson MI Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1 Clin Exp Immunol 1988 72 422–427
Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis Lancet 1988 2 706–709
North J, Situnayake RD, Tikly M et al Interleukin 1 beta, hand and foot bone mineral content and the development of joint erosions in rheumatoid arthritis Ann Rheum Dis 1994 53 543–546
Danis VA, Kulesz AJ, Nelson DS, Brooks PM The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis Clin Exp Immunol 1990 79 335–340
Chomarat P, Vannier E, Dechanet J et al The balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10 J Immunol 1995 154 1432–1439
Firestein GS, Boyle DL, Yu C et al Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis Arthritis Rheum 1994 37 644–652
di Giovine FS, Takhsh E, Blakemore AI, Duff GW Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta) Hum Mol Genet 1992 1 450
Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro Eur J Clin Invest 1992 22 396–402
Di Giovine FS, Cork MJ, Crane A, Mee JB, Duff GW Novel genetic association of an IL-1B gene variation at +3953 with IL-1 beta protein production and psoriasis Cytokine 1995 7 606 (Abstr. A665)
Demeter J, Messer G, Ramisch S et al Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies Cytokines Mol Ther 1996 2 239–242
Clay FE, Tarlow JK, Cork MJ, Cox A, Nicklin MJ, Duff GW Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment Hum Genet 1996 97 723–726
Bidwell J, Keen L, Gallagher G et al Cytokine gene polymorphism in human disease: on-line databases Genes Immun 1999 1 3–19
Heresbach D, Alizadeh M, Dabadie A et al Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases Am J Gastroenterol 1997 92 1164–1169
Bioque G, Crusius JB, Koutroubakis I et al Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease Clin Exp Immunol 1995 102 379–383
Larsen A, Dale K, Eek M Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films Acta Radiol Diagn (Stockh) 1977 18 481–491
van der Heijde DM Radiographic imaging: the ‘gold standard’ for assessment of disease progression in rheumatoid arthritis Rheumatology (Oxford) 2000 39 (Suppl 1) 9–16
van Zeben D, Hazes JM, Zwinderman AH et al Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow up study Arthritis Rheum 1991 34 822–830
Corbett M, Dalton S, Young A, Silman A, Shipley M Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years Br J Rheumatol 1993 32 717–723
Gabay C, Smith MF, Eidlen D, Arend WP Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein J Clin Invest 1997 99 2930–2940
Cantagrel A, Navaux F, Loubet-Lescoulie P et al Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis Arthritis Rheum 1999 42 1093–1100
Seidl C, Donner H, Fischer B et al CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis Tissue Antigens 1998 51 62–66
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis Rheumatology (Oxford) 2000 39 63–66
Cox A, Camp NJ, Cannings C et al Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis Hum Mol Genet 1999 8 1707–1713
Jouvenne P, Chaudhary A, Buchs N, di Giovine FS, Duff GW, Miossec P Possible genetic association between IL-1α gene polymorphism and the severity of arthritis Eur Cyt Netw 1999 10 33–36
Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease Gut 1998 43 33–39
Kornman KS, Crane A, Wang HY et al The interleukin-1 genotype as a severity factor in adult periodontal disease J Clin Periodontol 1997 24 72–77
Huang D, Pirskanen R, Hjelmstrom P, Lefvert AK Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis J Neuroimmunol 1998 81 76–81
Saxne T, Di Giovine FS, Heinegard D, Duff GW, Wollheim FA Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related J Autoimmun 1988 1 373–380
Danis VA, Millington M, Hyland VJ, Grennan D Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism Clin Exp Immunol 1995 99 303–310
Mandrup-Poulsen T, Pociot F, Molvig J et al Monokine antagonism is reduced in patients with IDDM Diabetes 1994 43 1242–1247
Dionne S, D’Agata ID, Hiscott J, Vanounou T, Seidman EG Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD) Clin Exp Immunol 1998 112 435–442
Schaid DJ, Sommer SS Genotype relative risks: methods for design and analysis of candidate-gene association studies Am J Hum Genet 1993 53 1114–1126
Freidel AC, Betuel H, Gebuhrer L, Farre A, Lambert J Cellular and serological subtypes of HLA-DR2 Tissue Antigens 1987 29 129–140
Jouvenne P, Vannier E, Dinarello CA, Miossec P Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction Arthritis Rheum 1998 41 1083–1089
Author information
Authors and Affiliations
Corresponding author
Additional information
These studies have been supported in part by grants from the Hospices Civils de Lyon, the European Union (Biomed-2 program contract BMH4-CT96-1698), the Association de Recherche sur la Polyarthrite (ARP) and the Arthritis Research Campaign for UK (ARC). Nicolas Buchs was supported by a fellowship from the Swiss National Science Foundation.
Rights and permissions
About this article
Cite this article
Buchs, N., di Giovine, F., Silvestri, T. et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels . Genes Immun 2, 222–228 (2001). https://doi.org/10.1038/sj.gene.6363766
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363766
Keywords
This article is cited by
-
IL-1 β gene (+3954 C/T, exon 5, rs1143634) and NOS2 (exon 22) polymorphisms associate with early aseptic loosening of arthroplasties
Scientific Reports (2022)
-
Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis
Rheumatology International (2022)
-
Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles
Drug Delivery and Translational Research (2022)
-
Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis
Molecular Biology Reports (2020)
-
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases
The Pharmacogenomics Journal (2013)